- 2301. Add/Insert
- (UMLS (HL7) C1548565) =Intellectual Product =Action Code;
◊ (UMLS (HL7) C1549771) Intellectual Product Segment action code; | - 2351. adenocarcinoma
- [carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures. ( CSP )] (UMLS (CSP) C0001418) =Neoplastic Process
|
- 2302. Added Concurrent Therapy
- [Instituted an additional therapy to mitigate potential negative effects ( HL7V3.0 )] (UMLS (HL7) C1555298) =Intellectual Product =Other Action Taken;
| - 2352. Adenocarcinoma and Small Cell Carcinoma of Lung
- [A lung carcinoma characterized by a combination of small cell carcinoma and adenocarcinoma. (NCI05) ( NCI )] (UMLS (NCI) C1332165) Adenocarcinoma and Small Cell Carcinoma of the Lung;
Adenocarcinoma and Small Cell Lung Carcinoma;
Combined Small Cell Lung Carcinoma and Lung Adenocarcinoma;
=Neoplastic Process ;
|
- 2303. Addendum
- [An appendage to an existing document that contains supplemental information. The parent document remains content is unaltered. ( NCI )] (UMLS (NCI) C1510776) =Intellectual Product
| - 2353. Adenocarcinoma Arising in Barrett's Mucosa
- [An adenocarcinoma arising from Barrett metaplastic epithelium in the esophagus. There is evidence supporting the idea that the Barrett adenocarcinomas develop through a stepwise progression through intestinal metaplastic epithelium to epithelial dysplasia to malignancy. Adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. In terms of grading, they are well or moderately differentiated adenocarcinomas. — 2002 ( NCI )] (UMLS (NCI) C1332460) Barrett Adenocarcinoma;
Barrett's Adenocarcinoma;
=Neoplastic Process ;
|
- 2304. Adderall
- (UMLS (NCI) C0290795) =Organic Chemical; Pharmacologic Substance ;
| - 2354. Adenocarcinoma Cell
- (UMLS (NCI) C1510779) Malignant Glandular Cell;
=Cell |
- 2305. Adderall XR
- (UMLS (NCI) C1170024) Adderall-XR =Organic Chemical; Pharmacologic Substance ;
| - 2355. Adenocarcinoma Cell with Eosinophilic Granular Cytoplasm
- (UMLS (NCI) C1510780) =Cell
|
- 2306. ADDH
- [A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-IV) ( MSH )] (UMLS (CSP) C1263846) ADHD;
ADHD (attention deficit hyperactivity disorder);
Attention deficit disorder of childhood with hyperactivity;
Attention Deficit Disorder with Hyperactivity;
attention deficit hyperactivity disorder;
ATTN DEFICIT W HYPERACT;
HYPERKINETIC SYND NOS;
Hyperkinetic syndrome of childhood;
Unspecified hyperkinetic syndrome of childhood =Mental or Behavioral Dysfunction =Attention Deficit and Disruptive Behavior Disorders;
| - 2356. Adenocarcinoma Cell with Intranuclear Inclusion
- (UMLS (NCI) C1510781) =Cell
|
- 2307. addiction
- [Uncontrollable craving, seeking, and use of a substance such as a drug or alcohol. ( NCI )] (UMLS (NCI) C0085281) =Mental or Behavioral Dysfunction
| - 2357. Adenocarcinoma Cell with Perinuclear Clearing
- (UMLS (NCI) C1510782) =Cell
|
- 2308. Addiction (Substance Use Disorder)
- (UMLS (HL7) C1555895) =Intellectual Product =Counselor;
◊ (UMLS (HL7) C1555901) Intellectual Product Psychologist; ◊ (UMLS (HL7) C1555965) Intellectual Product Registered Nurse; | - 2358. Adenocarcinoma in Adenomatous Polyp
- [A non-invasive or invasive adenocarcinoma arising from the neoplastic glandular cells in an adenomatous polyp. ( NCI )] (UMLS (NCI) C1321861) =Neoplastic Process ;
|
- 2309. Addiction Medicine
- (UMLS (HL7) C1555726) =Intellectual Product =Anesthesiology;
◊ (UMLS (HL7) C1555744) Intellectual Product Family Practice; ◊ (UMLS (HL7) C1555751) Intellectual Product Internal Medicine; ◊ (UMLS (HL7) C1555861) Intellectual Product Psychiatry & Neurology; | - 2359. Adenocarcinoma in Adenomatous Polyposis Coli
- [Adenocarcinomas developing in colorectal adenomas in patients with a history of adenomatous polyposis coli. The mean age of development of adenocarcinoma is about 40 years. ( NCI )] (UMLS (NCI) C0334293) =Neoplastic Process
|
- 2310. Addiction Psychiatry
- (UMLS (HL7) C1555862) =Intellectual Product =Psychiatry & Neurology;
| - 2360. Adenocarcinoma in Multiple Adenomatous Polyps
- [Adenocarcinomas developing in gastrointestinal tract adenomas in patients with multiple adenomatous polyps. ( NCI )] (UMLS (NCI) C0334295) =Neoplastic Process
|
- 2311. Addison's disease
- [disease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin; due to tuberculosis or autoimmune induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol. ( CSP )] (UMLS (CSP) C0001403) =Disease or Syndrome
| - 2361. Adenocarcinoma In Situ
- [A lesion in which the normally situated glands are partially or completely replaced by atypical cells with malignant characteristics. ( NCI )] (UMLS (NCI) C0334276) =Neoplastic Process
|
- 2312. Additional information
- (UMLS (HL7) C1546922) =Temporal Concept =Report timing;
| - 2362. Adenocarcinoma In Situ in a Polyp
- (UMLS (NCI) C1377630) =Neoplastic Process
|
- 2313. additional locator
- [This can be a unit designator, such as apartment number, suite number, or floor. There may be several unit designators in an address (e.g., "3rd floor, Appt. 342"). This can also be a designator pointing away from the location, rather than specifying a smaller location within some larger one (e.g., Dutch "t.o." means "opposite to" for house boats located across the street facing houses). ( HL7V3.0 )] (UMLS (HL7) C1550716) =Idea or Concept =AddressPartType;
=unit designator;
unit identifier;
| - 2363. Adenocarcinoma In Situ in Adenomatous Polyp
- [A non-invasive adenocarcinoma arising from the neoplastic glandular cells in an adenomatous polyp. ( NCI )] (UMLS (NCI) C0334290) =Neoplastic Process
|
- 2314. Additional payment for service not provided by Medicare
- (UMLS (HL7) C1547455) =Intellectual Product =OCE Edit Code;
| - 2364. Adenocarcinoma In Situ in Tubular Adenoma
- (UMLS (NCI) C1377632) =Neoplastic Process
|
- 2315. Additional tissue required
- (UMLS (HL7) C1547221) =Intellectual Product =Tissue Type Code;
| - 2365. Adenocarcinoma In Situ in Tubulovillous Adenoma
- [A non-invasive adenocarcinoma arising from a tubulovillous adenoma. ( NCI )] (UMLS (NCI) C0334308) =Neoplastic Process
|
- 2316. Additional X Chromosome
- (UMLS (NCI) C1510777) =Cell or Molecular Dysfunction
| - 2366. Adenocarcinoma In Situ in Villous Adenoma
- [A non-invasive adenocarcinoma arising from a villous adenoma. ( NCI )] (UMLS (NCI) C0334304) =Neoplastic Process
|
- 2317. Additive
- (UMLS (HL7) C1549547) =Idea or Concept =RX Component Type;
| - 2367. Adenocarcinoma in situ of Cervix
- (UMLS (NCI) C0346203) =Neoplastic Process
|
- 2318. additive
- [A substance that is added to a system or compound to improve its characteristics. ( NCI )] (UMLS (HL7) C1550602) =Substance =ingredient;
| - 2368. Adenocarcinoma in situ of Esophagus
- [Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.)-2003 ( NCI )] (UMLS (NCI) C0854764) Adenocarcinoma in situ of the Esophagus;
Esophageal Adenocarcinoma in situ;
Esophageal Adenocarcinoma, Stage 0;
Esophagus Adenocarcinoma in situ;
Oesophageal Adenocarcinoma Stage 0;
Stage 0 Adenocarcinoma of Esophagus;
Stage 0 Adenocarcinoma of the Esophagus;
Stage 0 Esophageal Adenocarcinoma;
Stage 0 Esophagus Adenocarcinoma;
=Neoplastic Process |
- 2319. additive, non-propagating
- [The association adds to the existing context associated with the Act, but will not propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Non-Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts for the purpose of this Act. However only the previously propagated authors will propagate to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552005) =Idea or Concept =ContextControlAdditive;
ContextControlNonPropagating | - 2369. Adenocarcinoma in situ of Lung
- [A non-small cell lung cancer (NSCLC), histologically classified as adenocarcinoma. Carcinoma in situ with no regional lymph node metastasis and no distant metastasis (Tis, N0, M0) (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C0854984) Adenocarcinoma in situ of the Lung;
Lung Adenocarcinoma in situ;
Lung Adenocarcinoma, Stage 0;
Stage 0 Adenocarcinoma of Lung;
Stage 0 Adenocarcinoma of the Lung;
Stage 0 Lung Adenocarcinoma =Neoplastic Process |
- 2320. additive, propagating
- [The association adds to the existing context associated with the Act, and will propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Additive, Propagating" it means that the author will be added to the set of author participations that have propagated from ancestor Acts, and will itself propagate with the other authors to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552003) =Idea or Concept =ContextControlAdditive;
ContextControlPropagating | - 2370. Adenocarcinoma in situ of Prostate
- (UMLS (NCI) C0154088) =Neoplastic Process
|
- 2321. Additive/Preservative
- (UMLS (HL7) C1547765) =Biomedical or Dental Material =HL7 Vocabulary Version 2.5;
=ACETIC ACID;
Polydesis;
Potassium/K EDTA;
Potassium Oxalate;
FLUORIDE (AS SODIUM FLUORIDE);
HEPARIN SODIUM;
fibrinogenase;
Thymol;
toluene;
Bouin's solution;
nitric acid;
Phenol;
ACD Solution A;
Sodium Fluoride 10 MG;
ACD Solution B;
Amies transport medium;
Bacterial Transport medium;
Buffered 10% formalin;
Borate Boric Acid;
Buffered skim milk;
3.2% Citrate;
3.8% Citrate;
Carson's Modified 10% formalin;
Cary Blair Medium;
Chlamydia transport medium;
CTAD (this should be spelled out if not universally understood);
Potassium/K EDTA 15%;
Potassium/K EDTA 7.5%;
Sodium/Na EDTA;
Enteric bacteria transport medium;
Enteric plus;
10% Formalin;
"Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products)"
;Sodium Fluoride, 100mg;
6N HCL;
Ammonium heparin;
Lithium/Li Heparin;
Jones Kendrick Medium;
Karnovsky's fixative;
Lithium iodoacetate;
M4;
M4-RT;
M5;
Michel's transport medium;
MMD transport medium;
Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride;
Pages's Saline;
Reagan Lowe Medium;
Siliceous earth, 12 mg;
SPS(this should be spelled out if not universally understood);
Serum Separator Tube (Polymer Gel);
Stuart transport medium;
Thyoglycollate broth;
Ureaplasma transport medium;
Viral Transport medium;
Buffered Citrate (Westergren Sedimentation Rate);
None | - 2371. Adenocarcinoma in Tubular Adenoma
- (UMLS (NCI) C1377621) =Neoplastic Process
|
- 2322. Address
- (UMLS (HL7) C1547327) =Intellectual Product =Value type;
| - 2372. Adenocarcinoma in Tubulovillous Adenoma
- [A non-invasive or invasive adenocarcinoma arising from a tubulovillous adenoma. ( NCI )] (UMLS (NCI) C0334309) =Neoplastic Process
|
- 2323. Address
- (UMLS (HL7) C1578437) =Intellectual Product =Data type;
| - 2373. Adenocarcinoma in Villous Adenoma
- [A non-invasive or invasive adenocarcinoma arising from a villous adenoma. ( NCI )] (UMLS (NCI) C0334305) =Neoplastic Process
|
- 2324. Address
- [For attributes representing the location at which an organization, person, or item may be found or reached. ( HL7V3.0 )] (UMLS (HL7) C1578436) =Intellectual Product =MDFAttributeType;
| - 2374. Adenocarcinoma NOS of the Mouse Pulmonary System
- (UMLS (NCI) C1510787) Adenocarcinoma of the Mouse Pulmonary System;
=Neoplastic Process |
- 2325. Address Part
- (UMLS (HL7) C1552678) =Idea or Concept =Character;
| - 2375. Adenocarcinoma of Ampulla of Vater
- [A carcinoma with glandular differentiation arising from the ampulla of Vater. Signs and symptoms include jaundice, abdominal pain, anorexia, nausea, vomiting, and weight loss. ( NCI )] (UMLS (NCI) C1332243) Ampulla of Vater Adenocarcinoma;
Ampullary Adenocarcinoma =Neoplastic Process ;
|
- 2326. Address type
- (UMLS (HL7) C1547607) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Firm/Business;
Bad address;
Birth delivery location (address where birth occurred);
Residence at birth (home address at time of birth);
Current Or Temporary;
Country Of Origin;
Home;
Legal Address;
Mailing;
Birth (nee) (birth address, not otherwise specified);
Office;
Permanent;
Registry home. Refers to the information system, typically managed by a public health agency, that stores patient information such as immunization histories or cancer data, regardless of where the patient obtains services. | - 2376. Adenocarcinoma of Anal Canal
- [An anal adenocarcinoma arising from the anal canal mucosa. Morphologically, it resembles the adenocarcinoma which arises from the colorectal glandular epithelium. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. ( NCI )] (UMLS (NCI) C1332259) Adenocarcinoma of the Anal Canal;
Anal Canal Adenocarcinoma =Neoplastic Process |
- 2327. AddressPartType
- [Discussion: The hierarchical nature of these concepts shows composition. E.g. "Street Name" is part of "Street Address Line" ( HL7V3.0 )] (UMLS (HL7) C1553795) =Intellectual Product =CodeSystem;
=postal code;
country;
state or province;
municipality;
additional locator;
county or parish;
street address line;
care of;
precinct;
building number suffix;
delivery address line;
census tract;
delimiter;
| - 2377. Adenocarcinoma of Anal Gland
- [An anal adenocarcinoma arising from the epithelium of the anal glands. The overlying anal mucosa does not show evidence of neoplastic changes. ( NCI )] (UMLS (NCI) C1266027) Adenocarcinoma of the Anal Gland;
Anal Glands Adenocarcinoma =Neoplastic Process |
- 2328. AddressUse
- (UMLS (HL7) C1698330) =Spatial Concept ;
=PostalAddressUse;
=job site;
home address;
temporary address;
birthplace | - 2378. Adenocarcinoma of Anus
- [An adenocarcinoma arising in the anal canal epithelium, including the mucosal surface, the anal glands, and the lining of fistulous tracts. The prognosis is related to the stage at diagnosis. — 2003 ( NCI )] (UMLS (NCI) C1332257) Adenocarcinoma of the Anus;
Anal Adenocarcinoma =Neoplastic Process ;
|
- 2329. adduct
- [compound produced by the mixing of two or more chemicals or a complex that forms when a chemical binds to a biological molecule, such as DNA or a protein. ( CSP )] (UMLS (CSP) C0596040) =Chemical Viewed Structurally ;
=chemical bond;
| - 2379. Adenocarcinoma of Anus within Anorectal Fistula
- [An anal adenocarcinoma arising from the lining of an anorectal fistulous tract. The overlying anal mucosa does not show evidence of neoplastic changes. Some cases are associated with Crohn disease. ( NCI )] (UMLS (NCI) C1332258) Adenocarcinoma of the Anus within Anorectal Fistula;
Anal Adenocarcinoma within Anorectal Fistula =Neoplastic Process |
- 2330. ADDUCTOR TENOTOMY OF HIP
- [ ] (UMLS (ICD9CM) C0407093) =Therapeutic or Preventive Procedure
| - 2380. Adenocarcinoma of Appendix
- [A malignant neoplasm arising from the glandular epithelium of the appendix with invasion of the appendiceal wall beyond the muscularis mucosa. The majority of cases are well differentiated adenocarcinomas with mucinous stroma formation. Clinically, it may present as an abdominal mass or with symptoms of acute appendicitis. Patients with chronic ulcerative colitis are at a higher risk in developing appendiceal adenocarcinomas compared to the general population. ( NCI )] (UMLS (NCI) C0238003) =Neoplastic Process
|
- 2331. ADE
- (UMLS (NCI) C0057163) =Therapeutic or Preventive Procedure
| - 2381. Adenocarcinoma of Bartholin's Gland
- (UMLS (NCI) C0238016) =Neoplastic Process
|
- 2332. AdEERS
- [A Web application developed for the electronic submission of Expedited Reports to the NCI for serious and/or unexpected Adverse Events, deaths, and other events defined in the NCI Guidelines: Adverse Event Reporting Requirements for NCI Investigational Agents ( NCI )] (UMLS (NCI) C1510820) Adverse Drug Experience Reporting System;
Adverse Event Expedited Reporting System =Intellectual Product | - 2382. Adenocarcinoma of Bladder
- [A rare adenocarcinoma arising from metaplastic bladder epithelium. It is frequently associated with long-standing local irritation. The majority of cases originate from the trigone and the posterior wall of the bladder. ( NCI )] (UMLS (NCI) C0279682) =Neoplastic Process
|
- 2333. Adefovir Dipivoxil
- [An acyclic nucleotide adenine analogue with potent antiviral activity. Adefovir is activated in vivo to a diphosphate metabolite which is incorporated into viral DNA, leading to viral RNA-dependent DNA polymerase inhibition, DNA chain termination and impairment of viral replication. This agent inhibits the reverse transcriptases of hepatitis B, herpes and HIV viruses, induces natural killer cell activity, and stimulates endogenous interferon production. Viral resistance to adefovir develops at a slower rate compared to other antivirals. (NCI04) ( NCI )] (UMLS (NCI) C0540694) =Organic Chemical; Pharmacologic Substance ;
=9-(2-phophonylmethoxyethyl)adenine;
Unclassified Ingredients =ADEFOVIR DIPIVOXIL 10 MG | - 2383. Adenocarcinoma of Breast
- (UMLS (NCI) C0858252) Adenocarcinoma of the Breast;
Breast Adenocarcinoma;
Mammary adenocarcinoma =Neoplastic Process |
- 2334. Adelaide River virus
- [ ] (UMLS (CSP) C0599348) =Virus ;
| - 2384. Adenocarcinoma of Cardia of Stomach
- (UMLS (NCI) C1333762) Adenocarcinoma of Gastric Cardia;
Adenocarcinoma of the Cardia of the Stomach;
Adenocarcinoma of the Gastric Cardia;
Gastric Cardia Adenocarcinoma;
=Neoplastic Process |
- 2335. adenase
- [ ] (UMLS (CSP) C0050739) =Amino Acid, Peptide, or Protein; Enzyme =aminohydrolase;
| - 2385. Adenocarcinoma of Cardioesophageal junction
- [Adenocarcinomas that straddle the gastroesophageal junction. This definition includes adenocarcinomas formerly called carcinomas of the gastric cardia. These carcinomas are more frequently seen in middle-aged and older white males and are associated with gastro-esophageal reflux. Adenocarcinomas in the gastroesophageal junction can be graded as well, moderately or poorly differentiated (adapted from WHO, 2000). ( NCI )] (UMLS (NCI) C1332166) Adenocarcinoma of Gastroesophageal Junction;
Adenocarcinoma of the Cardioesophageal junction;
Adenocarcinoma of the Gastroesophageal Junction;
Gastroesophageal Junction Adenocarcinoma =Neoplastic Process ;
|
- 2336. adenine analog
- [chemical compound with a structure similar to that of the purine base adenine capable of base pairing and base substitutions. ( CSP )] (UMLS (CSP) C0596041) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =purine analog;
=9-(2-phophonylmethoxyethyl)adenine;
| - 2386. Adenocarcinoma of Cecum
- (UMLS (NCI) C1332866) Adenocarcinoma of the Cecum;
Cecal Adenocarcinoma;
Cecum Adenocarcinoma;
=Neoplastic Process ;
|
- 2337. adenine nucleoside
- [purine base adenine attached to a ribose or deoxyribose. ( CSP )] (UMLS (CSP) C0596042) =Nucleic Acid, Nucleoside, or Nucleotide ;
=purine nucleoside;
=adenosine;
2-Fluoro-9-beta-arabinofuranosyladenine;
deoxyadenosine;
| - 2387. Adenocarcinoma of Cervix
- [Cervical adenocarcinomas account for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papilloma virus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type. ( NCI )] (UMLS (NCI) C0279672) =Neoplastic Process
|
- 2338. adenine nucleotide
- [condensation product of adenosine and phosphoric acid; a nucleotide found among the hydrolysis products of all nucleic acids. ( CSP )] (UMLS (CSP) C0001413) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance; Biologically Active Substance
| - 2388. Adenocarcinoma of Colon
- (UMLS (NCI) C0338106) =Neoplastic Process ;
|
- 2339. Adenine Nucleotide Translocator-1
- [Expressed in heart, kidney, liver, skeletal muscle by human SLC25A4 Gene (Mitochondrial Carrier Family), 298-aa 33-kDa homodimeric Adenine Nucleotide Translocator-1 is an integral membrane protein embedded asymmetrically in the inner mitochondrial membrane that catalyzes transmembrane exchange of ADP and ATP and determines the rate of ADP/ATP flux between mitochondrion and cytosol. Strongly similar to murine Ant1, ANT1 contains 3 solute carrier (Solcar) repeats and the signature RRRMMM motif of nucleotide carriers; six alpha helices form a compact transmembrane domain. Defects in SLC25A4 are a cause of PEO. ( NCI )] (UMLS (NCI) C1442881) ADP-ATP Translocase-1;
ANT;
ANT1;
Heart-Skeletal Muscle ADP-ATP Carrier Protein-T1;
Mitochondrial Adenine Nucleotide Translocator Solute Carrier Family 25 Member-4;
Skeletal Muscle Adenine Nucleotide Translocator-1;
T1 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 2389. Adenocarcinoma of Distal 1/3 of Common Bile Duct
- (UMLS (NCI) C1333307) Adenocarcinoma of the Distal 1/3 of the Common Bile Duct;
Distal 1/3 of Common Bile Duct Adenocarcinoma;
Distal 1/3 of the Common Bile Duct Adenocarcinoma =Neoplastic Process ;
|
- 2340. Adenine Nucleotide Translocator-3
- [Encoded by human SLC25A6 Gene (Mitochondrial Carrier Family), 298-aa 33-kDa homodimeric integral membrane protein Adenine Nucleotide Translocator-3 contains 3 Solcar repeats and plays a fundamental role in cellular energy metabolism by catalyzing ADP/ATP exchange across the inner mitochondrial membrane. ( NCI )] (UMLS (NCI) C0600151) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 2390. Adenocarcinoma of Duodenum
- (UMLS (NCI) C0278804) =Neoplastic Process
|
- 2341. adenine phosphoribosyltransferase
- [Human adenine phosphoribosyltransferase protein (179 aa, 19 kDa) is encoded by the human adenine phosphoribosyltransferase (APRT) gene. The cytoplasmic protein is primarily involved in an AMP purine salvage reaction that recycles adenine into nucleic acids by the formation of AMP from adenine and 5-phosphoribosyl-1-pyrophosphate. ( NCI )] (UMLS (CSP) C0001414) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 2391. Adenocarcinoma of Endometrium
- [An adenocarcinoma arising from the uterine body cavity. This is the most frequent malignant tumor affecting the uterine body, and is linked to estrogen therapy. Most patients present with uterine bleeding and are over age 40 at the time of diagnosis. The prognosis depends on the stage of the tumor, the depth of the uterine wall invasion, and the histologic subtype. Endometrioid adenocarcinoma is the most frequently seen morphologic variant of endometrial adenocarcinoma. — 2004 ( NCI )] (UMLS (NCI) C1153706) Adenocarcinoma of the Endometrium;
Endometrial Adenocarcinoma =Neoplastic Process |
- 2342. Adenine Phosphoribosyltransferase Gene
- [This gene plays a role in the purine salvage pathway. ( NCI )] (UMLS (NCI) C1366623) APRT;
APRT Gene =Gene or Genome | - 2392. Adenocarcinoma of Esophagus
- [Esophageal adenocarcinoma is a malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus. Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported. Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas. Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular. The prognosis is poor. —2002 ( NCI )] (UMLS (NCI) C0279628) =Neoplastic Process
|
- 2343. Adenitis
- [Inflammation of the lymph nodes. ( MSH )] (UMLS (NCI) C0024205) =Disease or Syndrome ;
=adenopathy;
=Cat-scratch disease;
MESENTERIC LYMPHADENITIS;
Lymph Node Tuberculosis;
Histiocytic Necrotizing Lymphadenitis | - 2393. Adenocarcinoma of Ethmoid Sinus
- (UMLS (NCI) C1333472) Adenocarcinoma of the Ethmoid Sinus;
Ethmoid Sinus Adenocarcinoma;
=Neoplastic Process ;
|
- 2344. adeno associated virus group
- [replication is dependent on a helper adenovirus; multiplies in cells which support adenovirus replication in many species of host. ( CSP )] (UMLS (CSP) C0001417) =Virus
| - 2394. Adenocarcinoma of Extrahepatic Bile Duct
- (UMLS (NCI) C0279659) =Neoplastic Process
|
- 2345. Adenoacanthoma
- [An invasive adenocarcinoma characterized by the presence of focal or extensive transformation of malignant glandular cells to squamous epithelial cells. ( NCI )] (UMLS (NCI) C0334393) =Neoplastic Process
| - 2395. Adenocarcinoma of Fallopian Tube
- (UMLS (NCI) C1333590) Adenocarcinoma of the Fallopian Tube;
Fallopian Tube Adenocarcinoma =Neoplastic Process ;
|
- 2346. Adenoacanthoma of Breast
- (UMLS (NCI) C1332613) Adenoacanthoma of the Breast;
Adenocarcinoma of Breast with Squamous Metaplasia;
Adenocarcinoma of the Breast with Squamous Metaplasia;
Breast Adenoacanthoma;
Breast Adenocarcinoma with Squamous Metaplasia =Neoplastic Process ;
| - 2396. Adenocarcinoma of Gallbladder
- (UMLS (NCI) C0279651) =Neoplastic Process
|
- 2347. Adenocanthoma of Endometrium
- [An endometrioid adenocarcinoma of the endometrium showing squamous differentiation. — 2004 ( NCI )] (UMLS (NCI) C0279763) =Neoplastic Process
| - 2397. Adenocarcinoma of Gallbladder with Squamous Metaplasia
- (UMLS (NCI) C0279655) =Neoplastic Process
|
- 2348. Adenocarcinofibroma
- (UMLS (NCI) C1510778) Malignant Adenofibroma;
=Neoplastic Process | - 2398. adenocarcinoma of kidney
- [cancerous kidney tumor composed of tubular cells; usually occurs in middle age or later in life; primary symptom is hematuria; nephrectomy is usually necessary. ( CSP )] (UMLS (CSP) C0007134) =Neoplastic Process ;
=adenocarcinoma;
kidney neoplasm |
- 2349. Adenocarcinoid Neoplasm
- [A malignant epithelial neoplasm composed of a mixture of neuroendocrine cells with morphologic and immunohistochemical characteristics of carcinoid tumor and malignant glandular cells. ( NCI )] (UMLS (NCI) C0334302) =Neoplastic Process
| - 2399. Adenocarcinoma of Kidney Pelvis
- (UMLS (NCI) C1335748) Adenocarcinoma of Renal Pelvis;
Adenocarcinoma of the Kidney Pelvis;
Adenocarcinoma of the Renal Pelvis;
Kidney Pelvis Adenocarcinoma;
Renal Pelvis Adenocarcinoma =Neoplastic Process |
- 2350. Adenocarcinoid Neoplasm of Appendix
- [A carcinoma arising from a pre-existing goblet cell carcinoid tumor of the appendix. The appendiceal mucosal epithelium is not involved by the neoplastic process. ( NCI )] (UMLS (NCI) C1332164) Adenocarcinoid Neoplasm of the Appendix;
Adenocarcinoid Tumor of Appendix;
Adenocarcinoid Tumor of the Appendix;
Appendiceal Adenocarcinoid;
Appendiceal Adenocarcinoid Neoplasm;
Appendiceal Adenocarcinoid Tumor;
Appendix Adenocarcinoid Neoplasm;
Appendix Adenocarcinoid Tumor;
Appendix Glandular Carcinoid Tumor;
Appendix Mixed Carcinoid-Adenocarcinoma =Neoplastic Process ;
| - 2400. Adenocarcinoma of Lacrimal Gland
- (UMLS (NCI) C0346341) =Neoplastic Process
|
home 
Armenian-English 
top